ENDPOINTS

Pfizer’s manufacturing arm at risk from Trump tariffs in Europe, Bourla says

Pfizer CEO Albert Bourla said its manufacturing business could be vulnerable to President Donald Trump’s tariffs in Europe as the big pharma has "significant" presence in the region. Its contract manufacturing arm Pfizer CentreOne has ...

Feb 19, 2025 - 12:24
 0
Pfizer’s manufacturing arm at risk from Trump tariffs in Europe, Bourla says
Pfizer CEO Albert Bourla said its manufacturing business could be vulnerable to President Donald Trump’s tariffs in Europe as the big pharma has "significant" presence in the region. Its contract manufacturing arm Pfizer CentreOne has ...
Read More

Tags:

Previous Article

Electrodes made from bread could replace metal conductors

Next Article

Trying to solve a key black hole mystery: Simulating magnetic flows around black...

Related Posts

In single case, spinal muscular atrophy drug given before birth spared baby of symptoms

In single case, spinal muscular atrophy drug given befo...

Feb 20, 2025  0

Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal

Roivant discontinues lung disease drug; Bio-Thera, Inta...

Feb 10, 2025  0

Novartis returns for its anticoagulant in up to $3.1B buy of Blackstone’s Anthos

Novartis returns for its anticoagulant in up to $3.1B b...

Feb 11, 2025  0